suramin has been researched along with transforming growth factor alpha in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 8 (88.89) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akpakip, B; Fang, K; Gallick, GE; Gazdar, AF; Putnam, EA; Roth, JA; Steck, PA; Yen, N | 1 |
| Cameron, L; Hoffman, R | 1 |
| Cardinali, M; Robbins, KC; Sartor, O | 1 |
| Kim, JH; Kozlowski, JM; Lee, C; Sherwood, ER; Sutkowski, DM | 1 |
| DeGeorges, A; Desgrandchamps, F; Tatoud, R; Thomas, F | 1 |
| Bruce, JN; Johnson, JP | 1 |
| Baldini, N; Benini, S; Chano, T; Lollini, PL; Manara, MC; Picci, P; Rizzi, S; Scotlandi, K; Serra, M | 1 |
| Pujade-Lauraine, E; Rodier, JM | 1 |
| Bergström, JD; Heldin, NE; Westermark, B | 1 |
2 review(s) available for suramin and transforming growth factor alpha
| Article | Year |
|---|---|
[Peptide growth factors in the prostate].
Topics: Adenocarcinoma; Epidermal Growth Factor; Fibroblast Growth Factors; Humans; Interleukin-6; Male; Nerve Growth Factors; Prostate; Prostatic Hyperplasia; Prostatic Neoplasms; Suramin; Transforming Growth Factor alpha; Transforming Growth Factor beta | 1993 |
Angiogenesis in human gliomas: prognostic and therapeutic implications.
Topics: Animals; Antineoplastic Agents; Brain Neoplasms; Cyclohexanes; Endothelial Growth Factors; Epidermal Growth Factor; Fibroblast Growth Factor 1; Fibroblast Growth Factor 2; Glioma; Humans; Lymphokines; Neovascularization, Pathologic; O-(Chloroacetylcarbamoyl)fumagillol; Prognosis; Sesquiterpenes; Suramin; Transforming Growth Factor alpha; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 1997 |
7 other study(ies) available for suramin and transforming growth factor alpha
| Article | Year |
|---|---|
Autocrine growth stimulation by transforming growth factor-alpha in human non-small cell lung cancer.
Topics: Animals; Carcinoma, Non-Small-Cell Lung; Dose-Response Relationship, Drug; ErbB Receptors; Humans; Lung Neoplasms; Mice; Mice, Nude; Neoplasm Transplantation; Radioligand Assay; Recombinant Proteins; RNA, Neoplasm; Suramin; Transforming Growth Factor alpha; Tumor Cells, Cultured; Tumor Stem Cell Assay | 1992 |
Characterization of a scintillation proximity assay to detect modulators of transforming growth factor alpha (TGF alpha) binding.
Topics: Antibodies, Monoclonal; Binding, Competitive; Cell Line; ErbB Receptors; Kinetics; Scintillation Counting; Suramin; Transforming Growth Factor alpha | 1992 |
Suramin, an experimental chemotherapeutic drug, activates the receptor for epidermal growth factor and promotes growth of certain malignant cells.
Topics: Cell Division; ErbB Receptors; Humans; KB Cells; Phosphorylation; Suramin; Transforming Growth Factor alpha; Tumor Cells, Cultured; Tyrosine | 1992 |
Inhibition of prostatic tumor cell proliferation by suramin: alterations in TGF alpha-mediated autocrine growth regulation and cell cycle distribution.
Topics: Antineoplastic Agents; Cell Cycle; Cell Division; Cell Line; Depression, Chemical; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; ErbB Receptors; Humans; Male; Prostatic Neoplasms; Suramin; Transforming Growth Factor alpha; Tumor Cells, Cultured | 1991 |
Redundancy of autocrine loops in human osteosarcoma cells.
Topics: Antineoplastic Agents; Autocrine Communication; Becaplermin; Bone Neoplasms; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Epidermal Growth Factor; Humans; Insulin-Like Growth Factor I; Insulin-Like Growth Factor II; Neoplasm Proteins; Nerve Growth Factors; Osteosarcoma; Platelet-Derived Growth Factor; Proto-Oncogene Proteins c-sis; Receptor, IGF Type 1; Receptors, Growth Factor; Suramin; Transforming Growth Factor alpha; Tumor Cells, Cultured | 1999 |
[Autocrine stimulation of cell proliferation in colonic carcinoma: a biological curiosity or a new therapeutic target?].
Topics: Antineoplastic Agents; Cell Division; Colonic Neoplasms; Epidermal Growth Factor; Humans; Neoplasm Invasiveness; Neoplasm Proteins; Somatostatin; Suramin; Transforming Growth Factor alpha; Tumor Cells, Cultured | 1995 |
Epidermal growth factor receptor signaling activates met in human anaplastic thyroid carcinoma cells.
Topics: Antineoplastic Agents; Butadienes; Carcinoma; Enzyme Inhibitors; ErbB Receptors; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Humans; MAP Kinase Kinase Kinase 1; MAP Kinase Signaling System; Mitogen-Activated Protein Kinases; Nitriles; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins c-met; Quinazolines; RNA, Messenger; Suramin; Thyroid Neoplasms; Transforming Growth Factor alpha; Tumor Cells, Cultured; Tyrphostins | 2000 |